Log In
Print this Print this

Cervatec ELISA

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionELISA assay for the quantitative determination p16INK4a protein in lysed samples from the cervix
Molecular Target Cyclin dependent kinase inhibitor 2A (CDKN2A) (INK4a) (ARF) (p16INK4a)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect pre-cancerous cervical lesions to help identify women with underlying high-grade cervical intraepithelial lesions
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today